Pharma LCA starts with the right data

Start with certified raw-material data, close gaps with custom modeling and scale your PAS 2090 approach with expert support.

Talk to a pharma LCA expert
See how we can help

WHY NOW?

Environmental requirements for pharmaceuticals are becoming more concrete

Regulators and buyers increasingly ask for product-level footprints. Robust raw-material data helps ensure your results stand up to scrutiny.

PAS 2090

Pharma-specific rules for Life Cycle Assessment

Published in November 2025, PAS 2090 provides product category rules for environmental LCAs of pharmaceutical products and creates a more consistent basis for conducting and reporting them.

France

Environmental criteria are entering public procurement

Environmental criteria are now required in French public procurement. For medicines, the public Score Carbone Médicament methodology provides a framework to assess their carbon footprint and support environmental criteria in tenders.

United Kingdom

The NHS supplier roadmap continues to expand

From April 2027, the NHS will introduce broader requirements for suppliers to report relevant global Scope 1, 2 and 3 emissions. From April 2028, new requirements are planned for carbon footprinting at individual product level.

Industry Key Challenges

Pharma LCA needs more than a calculation

The challenge is not producing one footprint. It is building a reliable system that works across complex products, specialized raw materials and evolving requirements.

01

Getting the right data for every raw material

Pharmaceuticals use diverse inputs, from APIs, excipients and solvents to intermediates and packaging. Getting suitable data for each one is a key requirement for reliable results.

02

Build your pharmaceutical LCA setup in-house

Consistent results depend on the right setup inside your company. Team capacity and skills, data collection, methodology and workflows all need to be defined, tested and scaled across your portfolio.

03

Turning rigorous LCA into a competitive advantage

Buyers and health systems increasingly ask for product footprints. A rigorous approach turns this requirement into a differentiator in upcoming tenders and sales discussions.

How we can help

Choose the support that fits your starting point

Option 01

Pharma Raw-Material Data

Close your raw-material data gaps

Access certified LCA data for 1,700+ chemical substances our database. Where a substance is missing, we model a dedicated dataset using our streamlined modeling approach.

Your outcome

Complete and consistent LCA data for all your raw materials.
Explore the Pharma Raw-Material Data

Option 02

Pharma LCA Implementation Service

Build a consistent approach to pharmaceutical LCA for your entire portfolio

Translate PAS 2090 and other relevant requirements into a practical LCA approach. We help you align your goals, build the required methodology and capabilities, test your approach and scale it across your portfolio.

Your outcome

LCA results for your entire portfolio and a solid process to keep them up-to-date.
Explore the Pharma LCA Implementation Service

Success story

How Bayer strengthens its environmental data foundation

Bayer aims to reach net zero across its value chain by 2050. To get there, the company integrates Carbon Minds PCF data into its central GHG Data Model, the backbone for its GHG accounting, reporting and its own PCF calculations.

 

Together, we mapped Bayer’s purchased goods to the Carbon Minds PCF library, and their license keeps the data continuously up to date.

Good data is essential for assessments, to facilitate discussions with suppliers, and to capture the impact of reductions.

Jens Plambeck,
Senior Manager Supplier Decarbonization
Bayer

YOUR PHARMA EXPERT

Dr. Leif Rohrbach

Project & Pharma Lead

Leif leads our activities in the pharmaceutical sector and supports companies from initial LCA strategy to implementation, combining pharmaceutical sustainability requirements with our expertise in chemical value chains.

 

Pharma knowledge hub

Learn more about pharma LCA

Upcoming

Roundtable・MID-DECEMBER 2026 (TBA)

Pharma Roundtable: practical implementation and open questions

A community session to discuss PAS 2090, data gaps and practical implementation with Carbon Minds experts and your industry peers.

On-Demand Webinar

Pharma LCA & PAS 2090: Closing Data Gaps Before New Requirements Take Effect

Identify missing emission factors, prioritize the gaps that matter and choose the right modeling depth for different pharmaceutical raw materials.

On-Demand Webinar

Recent Advances in Environmental Life Cycle Data for Pharmaceuticals

Insights from Bayer and Carbon Minds on retrosynthesis, AI and hybrid modeling approaches to expand data coverage for pharmaceutical chemicals.

Talk to our pharma team

Build the right foundation for your pharma LCA

Get in touch

Are you looking for better life cycle data? Evidence-based decision support? Executive training? Or something else?

Use this form to tell us what you’re interested in.